Seeking Alpha

Revance to offer shares

  • Revance Therapeutics (RVNC -1.2%) intends to offer 3M shares of common stock for public sale. Underwriters over-allotment will be 450K shares. Pricing will be announced after the SEC deems the prospectus effective.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs